BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15728581)

  • 1. Crystal structure of human cystatin D, a cysteine peptidase inhibitor with restricted inhibition profile.
    Alvarez-Fernandez M; Liang YH; Abrahamson M; Su XD
    J Biol Chem; 2005 May; 280(18):18221-8. PubMed ID: 15728581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for different inhibitory specificities of human cystatins C and D.
    Hall A; Ekiel I; Mason RW; Kasprzykowski F; Grubb A; Abrahamson M
    Biochemistry; 1998 Mar; 37(12):4071-9. PubMed ID: 9521728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
    Mason RW; Sol-Church K; Abrahamson M
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases.
    Hall A; Håkansson K; Mason RW; Grubb A; Abrahamson M
    J Biol Chem; 1995 Mar; 270(10):5115-21. PubMed ID: 7890620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site.
    Alvarez-Fernandez M; Barrett AJ; Gerhartz B; Dando PM; Ni J; Abrahamson M
    J Biol Chem; 1999 Jul; 274(27):19195-203. PubMed ID: 10383426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cystatin C variants with papain and human cathepsins B, H and L.
    Cimerman N; Prebanda MT; Turk B; Popovic T; Dolenc I; Turk V
    J Enzyme Inhib; 1999; 14(2):167-74. PubMed ID: 10445041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
    Estrada S; Pavlova A; Björk I
    Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
    Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
    Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
    Pavlova A; Björk I
    Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairpin loop mutations of chicken cystatin have different effects on the inhibition of cathepsin B, cathepsin L and papain.
    Auerswald EA; Nägler DK; Assfalg-Machleidt I; Stubbs MT; Machleidt W; Fritz H
    FEBS Lett; 1995 Mar; 361(2-3):179-84. PubMed ID: 7698319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The affinity and kinetics of inhibition of cysteine proteinases by intact recombinant bovine cystatin C.
    Olsson SL; Ek B; Björk I
    Biochim Biophys Acta; 1999 Jun; 1432(1):73-81. PubMed ID: 10366730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.
    Cheng T; Hitomi K; van Vlijmen-Willems IM; de Jongh GJ; Yamamoto K; Nishi K; Watts C; Reinheckel T; Schalkwijk J; Zeeuwen PL
    J Biol Chem; 2006 Jun; 281(23):15893-9. PubMed ID: 16565075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B.
    Auerswald EA; Nägler DK; Gross S; Assfalg-Machleidt I; Stubbs MT; Eckerskorn C; Machleidt W; Fritz H
    Eur J Biochem; 1996 Feb; 235(3):534-42. PubMed ID: 8654398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN.
    Hiltke TR; Lee TC; Bobek LA
    J Dent Res; 1999 Aug; 78(8):1401-9. PubMed ID: 10439027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elongation on the amino-terminal part of stefin B decreases inhibition of cathepsin H.
    Jerala R; Kroon-Zitko L; Popovic T; Turk V
    Eur J Biochem; 1994 Sep; 224(3):797-802. PubMed ID: 7925405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional characterization of two allelic variants of human cystatin D sharing a characteristic inhibition spectrum against mammalian cysteine proteinases.
    Balbín M; Hall A; Grubb A; Mason RW; López-Otín C; Abrahamson M
    J Biol Chem; 1994 Sep; 269(37):23156-62. PubMed ID: 8083219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
    Lalmanach G; Serveau C; Brillard-Bourdet M; Chagas JR; Mayer R; Juliano L; Gauthier F
    J Protein Chem; 1995 Nov; 14(8):645-53. PubMed ID: 8747425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
    Pol E; Björk I
    Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin L is capable of truncating cystatin C of 11 N-terminal amino acids.
    Popovic T; Cimerman N; Dolenc I; Ritonja A; Brzin J
    FEBS Lett; 1999 Jul; 455(1-2):92-6. PubMed ID: 10428479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of Stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases.
    Jenko S; Dolenc I; Guncar G; Dobersek A; Podobnik M; Turk D
    J Mol Biol; 2003 Feb; 326(3):875-85. PubMed ID: 12581647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.